Palatin Technologies
PTN
#10903
Rank
$11.7 M
Marketcap
$6.57
Share price
-3.60%
Change (1 day)
-48.39%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -$8.38 Million USD

According to Palatin Technologies's latest financial reports the company's current earnings are $13.18 Million USD. In 2025 the company made an earning of -$9.62 Million USD, an increase over its 2024 earnings that were of -$26.94 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$8.38 Million-12.98%
2025 -$9.62 Million-64.29%
2024 -$26.94 Million-16.9%
2023 -$32.42 Million5.99%
2022 -$30.59 Million-13.7%
2021 -$35.45 Million33.25%
2020 -$26.6 Million-172.11%
2019 $36.88 M2352.33%
2018 $1.5 M-94.13%
2017 $25.62 M-154.92%
2016 -$46.67 Million3.67%
2015 -$45.02 Million878%
2014 -$4.61 Million-72.64%
2013 -$16.83 Million-33.11%
2012 -$25.15 Million77.71%
2011 -$14.16 Million
2003 -$23.97 Million29.93%
2002 -$18.45 Million36.18%
2001 -$13.55 Million
1999 -$11.24 Million6.04%
1998 -$10.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$18.72 B-223,736.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$15.08 B-180,349.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$0.86 B-10,409.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-$10.75 Million 28.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$60.9 M-827.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-$0.12 Billion 1,305.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$0.15 B-1,985.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-$29.49 Million 252.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-$55.26 Million 560.06%๐Ÿ‡บ๐Ÿ‡ธ USA